70 related articles for article (PubMed ID: 10346921)
1. Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range.
Teodori E; Dei S; Quidu P; Budriesi R; Chiarini A; Garnier-Suillerot A; Gualtieri F; Manetti D; Romanelli MN; Scapecchi S
J Med Chem; 1999 May; 42(10):1687-97. PubMed ID: 10346921
[TBL] [Abstract][Full Text] [Related]
2. Novel multidrug resistance reversal agents.
Berger D; Citarella R; Dutia M; Greenberger L; Hallett W; Paul R; Powell D
J Med Chem; 1999 Jun; 42(12):2145-61. PubMed ID: 10377220
[TBL] [Abstract][Full Text] [Related]
3. Exploratory chemistry toward the identification of a new class of multidrug resistance reverters inspired by pervilleine and verapamil models.
Teodori E; Dei S; Garnier-Suillerot A; Gualtieri F; Manetti D; Martelli C; Romanelli MN; Scapecchi S; Sudwan P; Salerno M
J Med Chem; 2005 Nov; 48(23):7426-36. PubMed ID: 16279802
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L
Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (Pgp) dependent multidrug resistance (MDR) inhibitors.
Martelli C; Coronnello M; Dei S; Manetti D; Orlandi F; Scapecchi S; Novella Romanelli M; Salerno M; Mini E; Teodori E
J Med Chem; 2010 Feb; 53(4):1755-62. PubMed ID: 20104851
[TBL] [Abstract][Full Text] [Related]
6. Diphenylcyclohexylamine derivatives as new potent multidrug resistance (MDR) modulators.
Dei S; Budriesi R; Sudwan P; Ferraroni M; Chiarini A; Garnier-Suillerot A; Manetti D; Martelli C; Scapecchi S; Teodori E
Bioorg Med Chem; 2005 Feb; 13(4):985-98. PubMed ID: 15670906
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
Hasegawa T; Bai J; Dai J; Bai L; Sakai J; Nishizawa S; Bai Y; Kikuchi M; Abe M; Yamori T; Tomida A; Tsuruo T; Hirose K; Ando M
Bioorg Med Chem Lett; 2007 Jul; 17(13):3722-8. PubMed ID: 17490878
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
Schmidt M; Teitge M; Castillo ME; Brandt T; Dobner B; Langner A
Arch Pharm (Weinheim); 2008 Oct; 341(10):624-38. PubMed ID: 18816589
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
Lavie Y; Harel-Orbital T; Gaffield W; Liscovitch M
Anticancer Res; 2001; 21(2A):1189-94. PubMed ID: 11396162
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and multidrug-resistance modulating activity of a series of thienothiazines.
Chiba P; Erker T; Galanski M; Hitzler M; Ecker GF
Arch Pharm (Weinheim); 2002 May; 335(5):223-8. PubMed ID: 12210779
[TBL] [Abstract][Full Text] [Related]
11. New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR).
Orlandi F; Coronnello M; Bellucci C; Dei S; Guandalini L; Manetti D; Martelli C; Romanelli MN; Scapecchi S; Salerno M; Menif H; Bello I; Mini E; Teodori E
Bioorg Med Chem; 2013 Jan; 21(2):456-65. PubMed ID: 23245571
[TBL] [Abstract][Full Text] [Related]
12. Multidrug reverting activity toward leukemia cells in a group of new verapamil analogues with low cardiovascular activity.
Biscardi M; Teodori E; Caporale R; Budriesi R; Balestri F; Scappini B; Gavazzi S; Grossi A
Leuk Res; 2006 Jan; 30(1):1-8. PubMed ID: 16061283
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer.
Li Y; Zhang HB; Huang WL; Li YM
Bioorg Med Chem Lett; 2008 Jun; 18(12):3652-5. PubMed ID: 18502125
[TBL] [Abstract][Full Text] [Related]
14. Isomeric N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent P-glycoprotein (Pgp)-dependent multidrug resistance (MDR) inhibitors.
Teodori E; Martelli C; Salerno M; Darghal N; Dei S; Garnier-Suillerot A; Gualtieri F; Manetti D; Scapecchi S; Romanelli MN
J Med Chem; 2007 Feb; 50(4):599-602. PubMed ID: 17256837
[TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
Kars MD; Işeri OD; Gunduz U; Molnar J
Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
[TBL] [Abstract][Full Text] [Related]
16. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
17. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance reversal activity of permethyl ningalin B amide derivatives.
Tao H; Hwang I; Boger DL
Bioorg Med Chem Lett; 2004 Dec; 14(24):5979-81. PubMed ID: 15546712
[TBL] [Abstract][Full Text] [Related]
19. Benzo[b]-1,8-naphthyridine derivatives: synthesis and reversal activity on multidrug resistance.
Misbahi H; Brouant P; Hevér A; Molnár AM; Wolfard K; Spengler G; Mefetah H; Molnár J; Barbe J
Anticancer Res; 2002; 22(4):2097-101. PubMed ID: 12174889
[TBL] [Abstract][Full Text] [Related]
20. N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent transporter-dependent multidrug resistance inhibitors.
Martelli C; Alderighi D; Coronnello M; Dei S; Frosini M; Le Bozec B; Manetti D; Neri A; Romanelli MN; Salerno M; Scapecchi S; Mini E; Sgaragli G; Teodori E
J Med Chem; 2009 Feb; 52(3):807-17. PubMed ID: 19140665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
